Skip to main content

Table 1 Socio-demographic, health behaviour and biological measurements in the study population

From: The relationship between changes in health behaviour and initiation of lipid-lowering and antihypertensive medications in individuals at high risk of ischaemic heart disease

 

Blood pressure > 140 mmhg

Total cholesterol > 7 mmol/L

 

(n = 557)

(n = 314)

Sex

  

 Men

320 (57.5%)

187 (59.6%)

 Women

237 (42.5%)

127 (40.4%)

Age group (years)

  

 30-35

17 (3.1%)

13 (4.1%)

 40-55

266 (47.7%)

166 (52.9%)

 55-60

274 (49.2%)

135 (43.0%)

Educational level

  

 More than primary education

421 (75.6%)

66 (21.0%)

 Primary education only

131 (23.5%)

248 (79.0%)

 Missing

5 (0.9%)

 

Diabetes

  

 Positive test

9 (1.6%)

3 (1.0%)

Smoking status

  

 Daily

136 (24.4%)

107 (34.1%)

 Occasional

19 (3.4%)

11 (3.5%)

 Ex-smoker

172 (30.9%)

78 (24.8%)

 Never smoked

228 (40.9%)

118 (37.6%)

 Missing

2 (0.4%)

 

Alcohol

  

 Abstinent

50 (9.0%)

19 (6.0%)

 Within recommendations

385 (69.1%)

227 (72.3%)

 Above recommendations

103 (18.5%)

64 (20.4)

 Missing

19 (3.4%)

4 (1.3%)

Physical activity (minutes per week)

  

 0-112.5

59 (10.6%)

31 (9.9%)

 142.5-225

122 (21.9%)

79 (25.2%)

 255-420

263 (497.2%)

145 (46.2%)

 450-720

74 (13.3%)

31 (9.9%)

 Missing

39 (7.0%)

28 (8.9%)

Dietary habits

  

 Unhealthy dietary habit

88 (15.8%)

44 (14.0%)

 Average dietary habits

371 (66.7%)

215 (68.5%)

 Healthy dietary habits

83 (14.9%)

42 (13.4%)

 Missing

15 (2.7%)

13 (4.1%)

Body mass index, kg/m 2

  

 Mean

28.4

27.0

Systolic blood presure, mm/Hg a

  

 Mean

155.8

 

Cholesterol b

  

 Mean

 

7.7

At least one contact with GP

  

 Within 1 year after baseline

99.6%

100%

  1. a: Participants who report current use of antihypertensives (n = 128) were excluded.
  2. b: No participants reported use of lipid-lowering medications within the last few weeks.